Covi-G (powered by Cipla) Rapid Test kit combines quality, efficacy and convenience - offering precise results in 10-15 mins Features & Benefits Covid IgM-IgG Serologic Rapid Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies against SARS-CoV-2 in whole blood in vitro Precise and effective - Tests for both IgM and IgG antibodies - Sensitivity and specificity comparable to highest available offerings Sensitivity: IgG 92%, IgM 82%; Specificity IgG 97%, IgM 94% - ->92% total accuracy: IgG 96,5% - IgM: 92,8% - High reproducibility (consistent results across the same patient) - High quality, reliable & convenient - Single-prick blood test - 10-15 minutes per test - Intuitive visual interpretation - No specialized training or equipment needed - Portable hence highly scalable - Storage at room temperature (2-30 C) - Conformance to CE (Europe) and ISO manufacturing The Covi-G platform for Rapid Antibody tests has a set of unique and unparalleled offerings SUSTAINABLE QUALITY Validated Declaration of CE conformity - Launched in Feb 2020, among the earliest technologies/ kits to declare CE-compliance, and continuing strong compared to competitors - Under process for receiving USDA E authorization Among only 3 integrated vendors of Rapid tests Developed and manufactured in Europe (Belgium) - One of the very lew players manufacturing in Europe, with zero complaints also certified locations ACCEPTABILITY ACROSS MARKETS Demonstrated capabilities in local countries validation - Independent local studies conducted in Belgium and France, validating the sensitivity and specificity of the product Participated in published research - Covl-G kit compared lavorably with 7 lgFL IgM rapid antibody tests and IgG ELISA in a comparative study published by Elsevier Science Direct, verifying sensitivity of the kit PROVEN COMMERCIAL EXPERIENCE Sold in 25+ countries already - Including Europe, US, Canada, Africa and multiple developed and emerging markets - Under participation in govt tenders Robust manufacturing capability and capacity - ISO-certified manufacturing site - Ability to cater to high manufacturing volumes from Belgium, to ensure adequale QA and commercial viability AFFORDABLE AND SCALABLE Viable to scale up at Institutions and Retail level - Economical cost per-unit established over many months of process improvement and local manufacturing - Can cater to insured as well as out-of pocket populations Continuous improvement through R&D - Multiple rounds of performance testing complete, further testing in 5 reputed hospitals underway in Belgium, France, USA and Canada - Other platforms including Rapid antigen testing also being developed The price is per unit, the minimum is 25000 units
COVID 19 Rapid Test Kit - Approved already in several asian countries. Made in FDA approved facility. MOQ: 10,000
Diagnostic rapid test product, diagnostic reagent, recombinant protein, polyclonal and monoclonal antibody.
Rapid test kits.OEM
Covid 19 igg/igm rapid test kits .Consultant, Manufacturer
Ihealth rapid covid antigen tests.
Covid 19 rapid test kits.Product sourcing and trading
Rapid covid test.
Covid 19 Rapid Test Kit.
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Accuracy: 99.9% Sensitivity: 20 miu/ml Specimen: urine .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Accuracy: 99.9% Sensitivity: 20 miu/ml Specimen: urine .
The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals. This test has been authorized by the FDA under a EUA for professional use CLIA and CLIA WAIVED for Point Of Care. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This product is intended for professional use and not for home use. FACT SHEET FOR HEALTHCARE PROVIDERS This test has been authorized by the FDA under a EUA for use by authorized CLIA laboratories. This device is CLIA waived for point of care use for fingerstick whole blood specimens only. The user should be trained in the procedure. Wear appropriate protective attire for your safety when handling patient samples. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. There should be a blue line in the control region (next to ) before testing, discard the device if there is no blue line.
Animal diagnostic rapid test kits, veterinary kits.
3 ply mask. blue fda registered nitrle gloves covid 19 rapid test kits made in usa medica supply.
Surgical instruments, nitrile gloves, covid rapid test kits, ventilators, and other various ppe..
Covid Testing Kits.
We have just achieved a major breakthrough in the development of dengue igg/igm antibody early test. Our new product is capable to detect the presence of dengue igm antibody in human serum within 3-5 days since primary infection (tested and verified with reference standard blood sample from usa cdc), while similar products currently found on the market can only detect it after at least 10-15 days. The significance of this achievement is that the new dengue igg/igm antibody early test now can diagnose dengue infection at a very early stage, which previously could only be done with a dengue ns1 antigen test. Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Sensitivity: 95.3% Specificity: 95.0% Specimen: whole blood/serum/plasma .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Sensitivity: 94.3% Specificity: >98.9% Specimen: whole blood/serum/plasma .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Cut-off value: 1000 ng/ml Sensitivity: 99.5% Specificity: >99.7% Specimen: urine .
Rapid SAR-CoV-2 (Covid-19) Test Kits: FDA & CE Approved (Results in 15 min). SAR-CoV-2 IgG/IgM Rapid Test Cassette is a qualitative membrane based immunoassay for the detection of IgG and IgM antibodies to SAR-CoV-2 in human whole blood, serum or plasma specimen. Made in China: FDA and CE Approved, China NMPA approval (export allowed) One of the earliest CE (Feb 2020) and FDA (Mar 2020) approved kit. Clinically studied and reliable. Packaging: 20 sets/box or 40 sets/box. Payment term: MOQ 2000 sets, FOB China $ 9.5/set. < 10000 sets 100% advance payment > 10000 sets L/C ex-work on site
